Jim Omel

Medicine · Health Sciences

5h-index206citations22works1.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(22), Cancer Treatment and Pharmacology(8), Protein Degradation and Inhibitors(8), Insect Resistance and Genetics(4), Peptidase Inhibition and Analysis(4)

Publications22 total

Prophylactic interventions for oral toxicities with the GPRC5D×CD3 bispecific antibody talquetamab in relapsed/refractory multiple myeloma: An update on the open-label, phase 2, randomized TALISMAN study.
Journal of Clinical Oncology·2025
P-066 Prophylactic Interventions for Oral Toxicities With the GPRC5D×CD3 Bispecific Antibody Talquetamab in Relapsed/Refractory Multiple Myeloma: An Open-Label, Phase 2, Randomized Study (TALISMAN)
Clinical Lymphoma Myeloma & Leukemia·2024· 3 cited
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
Clinical Lymphoma Myeloma & Leukemia·2022· 6 citedOpen Access
Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study
Blood·2022· 4 cited
Quadruplet Induction, Autologous Transplantation and Minimal Residual Disease Adapted Consolidation and Treatment Cessation in Older Adults ≥70y with Newly Diagnosed Multiple Myeloma: A Subgroup Analysis of the Master Trial
Blood·2022· 1 cited
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next‐generation sequencing in multiple myeloma treated with quadruplet therapy
American Journal of Hematology·2022· 10 cited
Impact of lenalidomide-bortezomib-dexamethasone (RVd) induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect MM Registry.
Journal of Clinical Oncology·2020· 2 cited
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death.
Journal of Clinical Oncology·2020
Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study
Blood·2019· 19 cited
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy
Clinical Lymphoma Myeloma & Leukemia·2019
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry
Clinical Lymphoma Myeloma & Leukemia·2019
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry
Clinical Lymphoma Myeloma & Leukemia·2019· 1 cited
PS1384 TREATMENT CHOICES AND OUTCOMES FOR PATIENTS WITH MULTIPLE MYELOMA AFTER RELAPSE ON LENALIDOMIDE MAINTENANCE THERAPY: RESULTS FROM THE CONNECT® MM REGISTRY
HemaSphere·2019Open Access
PF601 EVOLVING TREATMENT PATTERNS IN MULTIPLE MYELOMA (MM) DIFFER BY AGE AND REGION: ANALYSIS FROM INSIGHT MM, A GLOBAL, PROSPECTIVE, OBSERVATIONAL STUDY
HemaSphere·2019· 2 citedOpen Access
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma
Future Oncology·2019· 29 citedOpen Access
Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study
Blood·2018· 4 cited
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study
Clinical Lymphoma Myeloma & Leukemia·2018· 5 cited
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update
Journal of Clinical Oncology·2018· 115 cited
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update
2018
Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187)
Clinical Lymphoma Myeloma & Leukemia·2017
page 1 of 2Next →

Frequent Co-authors

Robert M. Rifkin(13), Jesús G. Berdeja(11), Evangelos Terpos(11), Caitlin Costello(10), Faith E. Davies(10), Gordon Cook(10), Saad Z. Usmani(10), Jeffrey A. Zonder(10), Andrew Spencer(10), Michael A. Thompson(10), Dawn Marie Stull(10), Rafat Abonour(10), Noemí Puig(9), Xavier Leleu(9), Roman Hájek(9), Vânia Hungria(8), Jorge Vela‐Ojeda(7), Katja Weisel(7), Mario Boccadoro(7), Hans C. Lee(7)